Exact Mass: 357.0610398
Exact Mass Matches: 357.0610398
Found 45 metabolites which its exact mass value is equals to given mass value 357.0610398,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
TOLRESTAT
C16H14F3NO3S (357.06464500000004)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10X - Other drugs used in diabetes > A10XA - Aldose reductase inhibitors C471 - Enzyme Inhibitor > C72880 - Aldose Reductase Inhibitor D004791 - Enzyme Inhibitors
Cinolazepam
Cinolazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Cinolazepam is not approved for sale in the United States or Canada.Cinolazepam binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways. N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2,4-Dihydroxy-1,4-benzoxazin-3-one glucuronide
N1-(4-Chlorophenyl)-2-{amino[5-(trifluoromethyl)-2-pyridyl]methylidene}hydrazine-1-carboxamide
PRP_M358a
C15H17Cl2N3O3 (357.0646912000001)
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2401
PRP_M358b
C15H17Cl2N3O3 (357.0646912000001)
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2402
Cinolazepam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
4-(5-Bromopyrimidin-2-yloxy)piperidine-1-carboxylic acid tert-butyl
2-N-BOC-2-AMINOMETHYL-3-(4-BROMO-PHENYL)-PROPIONIC ACID
C15H20BrNO4 (357.0575620000001)
(2S)-3-amino-4-(3-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonyl]butanoic acid
C15H20BrNO4 (357.0575620000001)
2-N-BOC-2-AMINOMETHYL-3-(3-BROMO-PHENYL)-PROPIONIC ACID
C15H20BrNO4 (357.0575620000001)
2,2,2-Trifluoro-1-(4-methylphenyl)-O-[(4-methylphenyl)sulfonyl]oxime ethanone
C16H14F3NO3S (357.06464500000004)
Boc-(S)-3-amino-4-(4-bromophenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
boc-(r)-3-amino-4-(2-bromo-phenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
Boc-(S)-3-Amino-4-(2-bromo-phenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
BOC-(R)-3-amino-4-(4-bromo-phenyl)-butyric acid
C15H20BrNO4 (357.0575620000001)
1,3,5-Triazine,2-chloro-4-(1-dibenzofuranyl)-6-phenyl-
C21H12ClN3O (357.06688520000006)
2-Chloro-4-(4-dibenzofuranyl)-6-phenyl-1,3,5-triazine
C21H12ClN3O (357.06688520000006)
N-(6-acetamido-3-prop-2-enyl-1,3-benzothiazol-2-ylidene)-2-thiophenecarboxamide
2-(2,4-Dichlorophenyl)-alpha-methyl-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-ethanol
C15H17Cl2N3O3 (357.0646912000001)
(Z,4E)-4-[cyano-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethylidene]hex-2-enedioic acid
(2S-3S)-versiconal hemiacetal(1-)
A phenolate anion obtained by deprotonation of the 8-hydroxy group of (2S-3S)-versiconal hemiacetal. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
[4-(7-Chloro-4-quinolinyl)-1-piperazinyl]-thiophen-2-ylmethanone
C18H16ClN3OS (357.07025560000005)
2-[[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(2-pyridinyl)acetamide
C15H11N5O4S (357.05317260000004)
4-[[5-(1,3-Benzothiazol-2-yl)-2-thiophenyl]-oxomethyl]-1-piperazinecarboxaldehyde
1-[2-(4-Methoxyphenoxy)ethylthio]-[1,2,4]triazolo[3,4-b][1,3]benzothiazole
2-[(6-chloro-1H-benzimidazol-2-yl)thio]-N-(2,3-dihydro-1H-inden-5-yl)acetamide
C18H16ClN3OS (357.07025560000005)
(4-Chlorophenyl)-[1-(4-thieno[2,3-d]pyrimidinyl)-4-piperidinyl]methanone
C18H16ClN3OS (357.07025560000005)
2-(2,4-dichlorophenoxy)-N-[5-(2,2-dimethylpropyl)-1,3,4-oxadiazol-2-yl]acetamide
C15H17Cl2N3O3 (357.0646912000001)
4-Hydroxy-3-[(2-methoxyphenyl)diazenyl]naphthalene-1-sulfonate
C17H13N2O5S- (357.05451480000005)
Tnp-Gln
An L-alpha-amino acid that is L-glutamine substituted at the alpha-nitrogen by a 2,4,6-trinitrophenyl group.
1,4-dihydroxymidazolam
An imidazobenzodiazepine that is midazolam which is substituted by a hydroxy group at positions 2 and 4. It is the minor metabolite of the anesthetic, midazolam.
SR 16832
C17H12ClN3O4 (357.05163020000003)
SR 16832 is a dual site covalent PPARγ inhibitor that acts at orthosteric and allosteric sites[1].
(1r,4r,5s)-4-(2-bromoethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
C15H20BrNO4 (357.0575620000001)
(1s,4r,5s)-4-(2-bromoethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
C15H20BrNO4 (357.0575620000001)
4-(2-bromoethyl)-1-[cyclohex-2-en-1-yl(hydroxy)methyl]-3-hydroxy-5-methyl-6-oxa-2-azabicyclo[3.2.0]hept-2-en-7-one
C15H20BrNO4 (357.0575620000001)